Active

PHARMACEUTICAL ENTERPRISES BELGIUM

Switched

BE0455014924

Rechtspersoon Public limited company 1 establishment

Satenrozen 6A, 2550 Kontich Groothandel in farmaceutische en medische artikelen

Active for

31 year, 4 months

Financials

Financial year 2025

Worth noting

  • A loss two years in a row.
  • Figures corrected afterwards (2022).

Gross margin

€ 53,524

▼ 59% vs 2024

Profit

Caution

€ -96,338

▼ 761% vs 2024

Debts

Low

€ 32,595

▼ 93% vs 2024

PHARMACEUTICAL ENTERPRISES BELGIUM from Kontich, company number BE0455014924, closed financial year 2025 with a result of € -96,338 after tax. For that financial year PHARMACEUTICAL ENTERPRISES BELGIUM recorded a gross margin of € 53,524 and equity of € 69,896. Compared with financial year 2024, the result moved from € -11,191 to € -96,338. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What happened at PHARMACEUTICAL ENTERPRISES BELGIUM?

What happened at PHARMACEUTICAL ENTERPRISES BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 96,338. Source: NBB ↗
  • A-Pop Management CommV became a director. NBB
  • Swolfs Consultancy BV became a director. NBB
  • New establishment in Kontich. KBO
  • Start of the company according to the CBE. KBO

In short

From € 247,299 profit in 2021 to € 96,338 loss in 2025.

Paid € 99,222 in corporate taxes since 2021.

Best year ever: 2021, with € 247,299 profit.

On average € 210,200 of value added per employee in 2022.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACEUTICAL ENTERPRISES BELGIUM? We notify you, reason included.

Follow PHARMACEUTICAL ENTERPRISES BELGIUM

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

A-Pop Management CommV
Swolfs Consultancy BV
PHARMACEUTICAL ENTERPRISES BELGIUM
GLOBIPHARM
GLOBIFER INTL

Behind PHARMACEUTICAL ENTERPRISES BELGIUM are A-Pop Management CommV and Swolfs Consultancy BV. The same people are also behind GLOBIPHARM and GLOBIFER INTL.

See the full network in the app

Directors

According to the 2025 annual accounts

A-Pop Management CommV

Director · represented by Popowski Anthony

Also active at: GLOBIPHARM, GLOBIFER INTL

since 2020

Swolfs Consultancy BV

Managing director · represented by Swolfs Patrick

Also active at: GLOBIPHARM

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Satenrozen 6A box 2

2550 Kontich

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 13 companies are registered at this address.

CADIS

€ 986,725 gross margin · 2025

Straalstudio

Schilderstudio

€ 887,895 gross margin · 2025

BJ BTW EENHEID

Project Nekton

€ 486,955 gross margin · 2025

+8 more

Details

Company number
0455.014.924
VAT number
BE 0455.014.924
Registered office
Satenrozen 6A bus 2, 2550 Kontich
Names & denominations
PHARMACEUTICAL ENTERPRISES BELGIUM · Phare Belgium
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Einde van de opschorting
Start date
25 April 1995
Peppol
Active · Active since 27 Mar 2026
Activities · NACE

Groothandel in farmaceutische en medische artikelen

Groothandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What is the enterprise number of PHARMACEUTICAL ENTERPRISES BELGIUM?
The enterprise number of PHARMACEUTICAL ENTERPRISES BELGIUM is BE0455014924.
What is the address of PHARMACEUTICAL ENTERPRISES BELGIUM?
The registered office of PHARMACEUTICAL ENTERPRISES BELGIUM is located at Satenrozen 6A box 2, 2550 Kontich.
When was PHARMACEUTICAL ENTERPRISES BELGIUM founded?
PHARMACEUTICAL ENTERPRISES BELGIUM was founded on 25 April 1995.
What is the main activity of PHARMACEUTICAL ENTERPRISES BELGIUM?
The main activity of PHARMACEUTICAL ENTERPRISES BELGIUM is "Groothandel in farmaceutische en medische artikelen" (NACE code 46460).
Does PHARMACEUTICAL ENTERPRISES BELGIUM have a website?
No website is currently known for PHARMACEUTICAL ENTERPRISES BELGIUM.
How much profit did PHARMACEUTICAL ENTERPRISES BELGIUM make in 2025?
PHARMACEUTICAL ENTERPRISES BELGIUM recorded a loss after taxes of € 96,338 in financial year 2025.
What is the revenue of PHARMACEUTICAL ENTERPRISES BELGIUM?
As a small company, PHARMACEUTICAL ENTERPRISES BELGIUM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 53,524.
How many employees does PHARMACEUTICAL ENTERPRISES BELGIUM have?
According to the 2025 annual accounts, PHARMACEUTICAL ENTERPRISES BELGIUM has 0.8 full-time equivalents (FTE).
Where can I find the annual accounts of PHARMACEUTICAL ENTERPRISES BELGIUM?
PHARMACEUTICAL ENTERPRISES BELGIUM files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of PHARMACEUTICAL ENTERPRISES BELGIUM?
According to the 2025 annual accounts, the directors of PHARMACEUTICAL ENTERPRISES BELGIUM are: A-Pop Management CommV, Swolfs Consultancy BV.
Who owns PHARMACEUTICAL ENTERPRISES BELGIUM?
Behind PHARMACEUTICAL ENTERPRISES BELGIUM are A-Pop Management CommV and Swolfs Consultancy BV. The same people are also behind GLOBIPHARM and GLOBIFER INTL.